Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Eur Acad Dermatol Venereol ; 35(9): 1865-1873, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34013600

RESUMO

BACKGROUND: Descriptions of cutaneous findings associated with COVID-19 have not been consistently accompanied by histopathology or confirmatory testing for SARS-CoV-2. OBJECTIVE: To describe and classify the cutaneous findings with supporting histopathology of confirmed COVID-19 inpatients. METHODS: We included consecutive inpatients with a confirmed diagnosis of COVID-19 for whom a dermatology consult was requested. A skin biopsy was performed in all cases. Skin findings were classified as being compatible with a cutaneous manifestation of COVID-19 or as representing a distinct clinical entity. RESULTS: Twenty-eight patients were studied in whom thirty-one dermatologic diagnoses were made. Twenty-two of the dermatoses were compatible with a cutaneous manifestation of COVID-19; nine entities were not associated with infection by SARS-CoV-2. The most common COVID-19-associated pattern was an exanthematous presentation. In four patients, a new pattern was observed, characterized by discrete papules with varied histopathological findings including a case of neutrophilic eccrine hidradenitis. No cases of pernio-like lesions were identified. Skin findings not associated with COVID-19 represented 29% of diagnoses and included Malassezia folliculitis, tinea, miliaria and contact dermatitis. LIMITATIONS: There is no gold-standard test to distinguish between viral exanthems and drug reactions. CONCLUSION: A histopathological study is critical before attributing skin findings to a manifestation of COVID-19.


Assuntos
COVID-19 , Pérnio , Dermatopatias , Humanos , SARS-CoV-2 , Pele
3.
Environ Monit Assess ; 190(11): 683, 2018 Oct 29.
Artigo em Inglês | MEDLINE | ID: mdl-30374778

RESUMO

Technological advances in the field of underwater video have led to an exponential increase in the use of drifting cameras (DC) and remotely operated vehicles (ROVs) to monitor the diversity, abundance, and size structure of marine life. Main advantages of DCs relative to ROVs are their lower costs and the much simpler logistics required to operate them. This study compares the performance of a new low-cost DC system equipped with a novel measuring device with that of a standard DC bearing an array of laser pointers. The new DC, which can be operated from a small boat, carries a pair of parallel steel "whiskers" that are dragged on the seabed within the field of view of the camera, providing a scale for measuring and estimating the density of benthic biota. An experiment conducted using an array of objects of known sizes laid on the bottom showed that its performance in terms of both size and density estimation was similar to that of the standard technique based on laser pointers. Measurement errors had a negligible negative bias (- 2.3%) and a standard deviation that ranged between 13 and 8% for objects from 25 to 110 mm in size. The whiskers offered a simplified method for density estimation that avoids the need to calculate the width of the field of view, thus reducing the video processing time by around 60% with respect to the standard method. Briefly, the new system offers an efficient low-cost alternative for benthic ecology studies conducted on soft or non-irregular bottoms.


Assuntos
Monitoramento Ambiental/métodos , Tecnologia de Sensoriamento Remoto/instrumentação , Tecnologia de Sensoriamento Remoto/métodos , Gravação em Vídeo/instrumentação , Gravação em Vídeo/métodos , Animais , Organismos Aquáticos , Biota , Humanos , Processamento de Imagem Assistida por Computador/instrumentação , Processamento de Imagem Assistida por Computador/métodos
4.
J Fish Biol ; 89(2): 1258-70, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27282324

RESUMO

This study aimed to estimate trophic discrimination factors (TDFs) and metabolic turnover rates of nitrogen and carbon stable isotopes in blood and muscle of the smallnose fanskate Sympterygia bonapartii by feeding six adult individuals, maintained in captivity, with a constant diet for 365 days. TDFs were estimated as the difference between δ(13) C or δ(15) N values of the food and the tissues of S. bonapartii after they had reached equilibrium with their diet. The duration of the experiment was enough to reach the equilibrium condition in blood for both elements (estimated time to reach 95% of turnover: C t95%blood = 150 days, N t95%blood = 290 days), whilst turnover rates could not be estimated for muscle because of variation among samples. Estimates of Δ(13) C and Δ(15) N values in blood and muscle using all individuals were Δ(13) Cblood = 1·7‰, Δ(13) Cmuscle = 1·3‰, Δ(15) Nblood = 2·5‰ and Δ(15) Nmuscle = 1·5‰, but there was evidence of differences of c.0·4‰ in the Δ(13) C values between sexes. The present values for TDFs and turnover rates constitute the first evidence for dietary switching in batoids based on long-term controlled feeding experiments. Overall, the results showed that S. bonapartii has relatively low turnover rates and isotopic measurements would not track seasonal movements adequately. The estimated Δ(13) C values in S. bonapartii blood and muscle were similar to previous estimations for elasmobranchs and to generally accepted values in bony fishes (Δ(13) C = 1·5‰). For Δ(15) N, the results were similar to published reports for blood but smaller than reports for muscle and notably smaller than the typical values used to estimate trophic position (Δ(15) N c. 3·4‰). Thus, trophic position estimations for elasmobranchs based on typical Δ(15) N values could lead to underestimates of actual trophic positions. Finally, the evidence of differences in TDFs between sexes reveals a need for more targeted research.


Assuntos
Isótopos de Carbono/metabolismo , Isótopos de Nitrogênio/metabolismo , Rajidae/metabolismo , Animais , Isótopos de Carbono/análise , Isótopos de Carbono/sangue , Isótopos de Carbono/química , Dieta , Comportamento Alimentar/fisiologia , Feminino , Masculino , Músculos/química , Músculos/metabolismo , Isótopos de Nitrogênio/análise , Isótopos de Nitrogênio/sangue , Isótopos de Nitrogênio/química , Estado Nutricional
5.
Clin Transl Oncol ; 11(5): 290-301, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19451062

RESUMO

Pancreatic cancer (PC) represents one of the greatest oncological challenges of our century, due to its high mortality and incidence. A group of Spanish experts in PC treatment reviewed data available on different therapeutic combinations and established consensus on what would be the best strategy in PC management, depending on the stage of the disease. Surgery with complete resection may produce 5-year survival rates of 18-24%, but definitive control is still precarious. In the absence of consensus, the best evidence suggests that adjuvant chemotherapy with gemcitabine for 6 months using the CONKO-001 regime is the treatment of choice after resection of PC for patients with acceptable functional status. This group recommends chemoradiotherapy (CT-RT) in patients with factors for poor loco-regional prognosis. However, chemotherapy is an option for the treatment of locally advanced PC in patients with good general status and in the absence of metastatic disease the recommended treatment is CT-RT followed by gemcitabine-based chemotherapy. A period of chemotherapy followed by consolidation CT-RT may be appropriate, as it allows selection of patients with locally advanced disease who may benefit most from combined treatment. Erlotinib combined with gemcitabine shows significant survival improvement in PC and must be considered an option in the first-line treatment of advanced and metastatic PC. The gemcitabine-erlotinib combination is proposed as the standard treatment for metastatic PC in patients with PS=/>2. In patients with PS<2, gemcitabine-erlotinib is recommended as the first-line treatment option, supported by a maximum degree of evidence, without ruling out other options, such as gemcitabine-oxaliplatin, gemcitabine-capecitabine or gemcitabine alone.


Assuntos
Neoplasias Pancreáticas/terapia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Terapia Combinada , Humanos , Estadiamento de Neoplasias , Pancreatectomia , Neoplasias Pancreáticas/patologia , Radioterapia , Espanha
6.
Br J Ophthalmol ; 88(8): 1074-7, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15258028

RESUMO

BACKGROUND: Retinoblastoma (RB) is a relatively uncommon tumour in childhood. The incidence of retinoblastoma in Mexico is probably higher than the incidence reported worldwide, however there is not enough information about the characteristics of this illness in Mexico. This report aims to present the results of a multicentre clinical survey of RB in Mexico. METHODS: A retrospective study was carried out on all RB cases treated in 16 institutions during the last six years. The variables analysed were age at diagnosis, sex, affected eyes, treatment modalities, and pathological staging. Overall survival was obtained. RESULTS: The authors analysed 500 cases; age range was 0-182 months. There were 364 unilateral cases (72.8%). Enucleation was performed in 84.9% of the patients. The St Jude's staging was: 7.4% stage I, 52.8% stage II, 18.0% stage III, 11.4% stage IV, 7.2% not evaluated, and 3.2% missing data. Chemotherapy was used in 74.4% of the patients. Disease free survival was 89% at 73 months follow up. CONCLUSIONS: The paper presents a great number of cases and pioneers multicentre studies in paediatric ophthalmology and oncology in this country. Given the great number of patients in advanced stages and the variability on treatment schemes, it is evident that it is mandatory to work in a cooperative group and develop a national early detection programme as well as a treatment protocol which include all specialists involved in the care of patients with RB.


Assuntos
Neoplasias da Retina/epidemiologia , Retinoblastoma/epidemiologia , Adolescente , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Criança , Pré-Escolar , Enucleação Ocular , Feminino , Humanos , Incidência , Lactente , Recém-Nascido , Masculino , México/epidemiologia , Estadiamento de Neoplasias , Neoplasias da Retina/mortalidade , Neoplasias da Retina/terapia , Retinoblastoma/mortalidade , Retinoblastoma/terapia , Estudos Retrospectivos , Distribuição por Sexo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA